Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence-based indications for postmastectomy irradiation.

Abram Recht1, Stephen B Edge

  • 1Department of Radiation Oncology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. arecht@caregroup.harvard.edu

The Surgical Clinics of North America
|July 24, 2003
PubMed
Summary

Postmastectomy radiation therapy (PMRT) improves survival for breast cancer patients with positive lymph nodes. However, its benefits vary, with routine use recommended for specific high-risk groups.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Tamoxifen Only After Lumpectomy for "Good-Risk" Duct Carcinoma In Situ: Combined Analysis of the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 Trials.

International journal of radiation oncology, biology, physics·2026
Same author

Omitting Radiation for Breast Cancer Patients Eligible for the NSABP B-51 Trial Who Achieve ypN0 After Neoadjuvant Chemotherapy.

Practical radiation oncology·2026
Same author

Radiation Dose and Lymphedema Risk After Immediate Lymphatic Reconstruction and Axillary Lymph Node Dissection.

International journal of radiation oncology, biology, physics·2026
Same author

Impact of a technology enhanced breast multidisciplinary cancer conference.

Surgical oncology insight·2025
Same author

Who Needs Axillary Dissection After Neoadjuvant Therapy?

JAMA oncology·2025
Same author

Beyond TNM staging: Machine learning of individualized colon cancer outcomes.

Surgery·2025

Area of Science:

  • Oncology
  • Radiation Oncology
  • Breast Cancer Research

Background:

  • Postmastectomy radiation therapy (PMRT) is a critical component of breast cancer treatment.
  • Its role in reducing recurrence and improving survival in patients with involved axillary lymph nodes is established.
  • However, the precise benefit across different patient subsets requires ongoing evaluation.

Purpose of the Study:

  • To summarize the American Society of Clinical Oncology (ASCO) guidelines panel's findings on the use of PMRT.
  • To define patient populations for whom PMRT is indicated or for whom evidence is insufficient.

Main Methods:

  • Systematic review and guideline development by the ASCO expert panel.
  • Analysis of existing evidence regarding PMRT efficacy in invasive breast cancer with positive axillary nodes.

Related Experiment Videos

Main Results:

  • PMRT significantly reduces local-regional and distant recurrence risks and improves survival.
  • Routine PMRT is indicated for patients with four or more positive axillary nodes, tumors >5 cm, or locally advanced cancers.
  • Insufficient evidence exists to recommend PMRT for T1-2 tumors with 1-3 positive nodes or all patients receiving neoadjuvant therapy.

Conclusions:

  • PMRT offers survival benefits for specific high-risk breast cancer patients with positive lymph nodes.
  • Further research, including participation in clinical trials, is crucial for optimizing PMRT use in intermediate-risk groups.